Zobrazeno 1 - 10
of 241
pro vyhledávání: '"Masaki, Fujiwara"'
Autor:
Takashi Fukao, Masaki Fujiwara, Yuto Yamada, Shinji Sakamoto, Yosuke Matsumoto, Manabu Takaki
Publikováno v:
PCN Reports, Vol 3, Iss 3, Pp n/a-n/a (2024)
Abstract Background Inattention due to attention‐deficit/hyperactivity disorder (ADHD) can lead to forgetfulness. Transient epileptic amnesia (TEA) can cause forgetfulness, similar to ADHD. We report a patient with ADHD who developed TEA. Case Pres
Externí odkaz:
https://doaj.org/article/1945fef68b284563abc0b6bc423e1591
Publikováno v:
PCN Reports, Vol 3, Iss 3, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/f63a639949a64d40b84b9cf7c9477a46
Autor:
Masaki Fujiwara, Osamu Yokota, Tomoko Miki, Seishi Terada, Shintaro Takenoshita, Katsuhide Kojima, Naoto Nishikawa, Manabu Takaki
Publikováno v:
BMJ Mental Health, Vol 27, Iss 1 (2024)
Background It has been reported that patients with geriatric psychiatric disorders include many cases of the prodromal stages of neurodegenerative diseases. Abnormal 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane dopamine tran
Externí odkaz:
https://doaj.org/article/7bd394fae7ad44efb8dd06a0cf85764c
Autor:
Masaki Fujiwara, Yuto Yamada, Tsuyoshi Etoh, Taichi Shimazu, Masafumi Kodama, Norihito Yamada, Takahiro Asada, Shigeo Horii, Takafumi Kobayashi, Teruo Hayashi, Yoshitaka Ehara, Kenji Fukuda, Keita Harada, Maiko Fujimori, Miyuki Odawara, Hirokazu Takahashi, Shiro Hinotsu, Naoki Nakaya, Yosuke Uchitomi, Masatoshi Inagaki
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-12 (2024)
Abstract Background People with schizophrenia have a lower colorectal screening rate than the general population. A previous study reported an intervention using case management to encourage colorectal cancer screening for patients with schizophrenia
Externí odkaz:
https://doaj.org/article/12bb87cfc98d4575bdb3d9cedd3582d5
Autor:
Keishiro Yagyu, MD, Masao Takemoto, MD, PhD, Masaki Fujiwara, MD, PhD, Yoshibumi Antoku, MD, PhD, Tokushi Koga, MD, PhD, Takuya Tsuchihashi, MD, PhD
Publikováno v:
HeartRhythm Case Reports, Vol 8, Iss 9, Pp 643-649 (2022)
Externí odkaz:
https://doaj.org/article/5a33c5eb5ae048d28c8262876482ef28
Autor:
Tempei Miyaji, Yosuke Uchitomi, Hiroyuki Okada, Masatoshi Inagaki, Maiko Fujimori, Taichi Shimazu, Masaki Fujiwara, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Hirokazu Takahashi, Naoki Nakaya, Shiro Hinotsu, Keita Harada, Norihito Yamada, Yuto Yamada, Tsuyoshi Etoh
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b6d12275ac684f38829c1af12ff01e73
Autor:
Arihide Okahara, Jun-ichiro Koga, Tetsuya Matoba, Masaki Fujiwara, Masaki Tokutome, Gentaro Ikeda, Kaku Nakano, Masaki Tachibana, Tetsuro Ago, Takanari Kitazono, Hiroyuki Tsutsui, Kensuke Egashira
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Abstract Ischemia–reperfusion injury impairs the efficacy of reperfusion therapy after ischemic stroke. Cyclophilin D (CypD)-mediated openings of mitochondrial permeability transition pore (mPTP) and subsequent monocyte-mediated inflammation are co
Externí odkaz:
https://doaj.org/article/929409dd3f8a48648a7dd82691a4b1ce
Autor:
Yuji Higuchi, Masaki Fujiwara, Naoki Nakaya, Maiko Fujimori, Chinatsu Hayashibara, Ryuhei So, Ikuta Shinkawa, Kojiro Sato, Yuji Yada, Masafumi Kodama, Hiroshi Takenaka, Yoshiki Kishi, Kyoko Kakeda, Yosuke Uchitomi, Norihito Yamada, Masatoshi Inagaki
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. Methods Participants were outpatients with schizophrenia aged 20–69 years who had been visiting the hospit
Externí odkaz:
https://doaj.org/article/a2bd60bac24f403a93d5a2312ffd4d19
Autor:
Kenta Yamaoka, Masaki Fujiwara, Mayako Uchida, Yoshihiro Uesawa, Nobuyuki Muroi, Tadashi Shimizu
Publikováno v:
Life, Vol 12, Iss 9, p 1355 (2022)
Poly (ADP-ribose) polymerase (PARP) inhibitors are effective against breast cancer susceptibility gene (BRCA) mutations. Clinical trials have reported hematologic toxicity and gastrointestinal symptoms as class effects of PARP inhibitors. However, in
Externí odkaz:
https://doaj.org/article/e4e19e853cd34a2185afb6534ab12f6e
Publikováno v:
Oncology. :1-6
Background: Proteasome inhibitors (PIs) are standard treatments for multiple myeloma (MM). The risk of cardiac adverse events (CAEs) with PIs has been documented with bortezomib and carfilzomib; however, only a few studies have been reported on ixazo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::014466a02631063c3b627b13369abef3
https://doi.org/10.1159/000529341
https://doi.org/10.1159/000529341